Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa

New England Journal of Medicine

Volumn 321, Issue 22, 1989, Pages 1501-1506

  Davis, Gary L ^a   Balart, Luis A ^a   Schiff, Eugene R ^a   Lindsay, Karen ^a   Bodenheimer, Henry C ^a   Perrillo, Robert P ^a   Carey, William ^a   Jacobson, Ira M ^a   Payne, John ^a   Dienstag, Jules L ^a   Vanthiel, David H ^a   Tamburro, Carlo ^a   Lefkowitch, Jay ^a   Albrecht, Janice ^a   Meschievitz, Carlton ^a   Ortego, Terryl J ^a   Gibas, Alexandra ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED STUDY; DRUG THERAPY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ALANINE TRANSAMINASE; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMAN; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGE; MULTICENTER STUDIES; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024368522     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198911303212203     Document Type: Article

References (18)

1. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983; 85: 439–62.
2. Alter HJ. Transfusion-associated non-A, non-B hepatitis: the first decade. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R. Liss, 1988:537–42.
3. Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B post-transfusion hepatitis — a decade later. Gastroenterology 1985; 88: 1251–4.
4. Pappas SC, Hoofnagle JH, Young N, Straus SE, Jones EA. Treatment of chronic non-A, non-B hepatitis with acyclovir: pilot study. J Med Virol 1985; 15: 1–9.
5. Stokes P, Lopez WC, Balart LA. Effects of short-term corticosteroid therapy in patients with chronic non-A, non-B hepatitis (NANB). Gastroenterology 1987; 92: 1783. abstract.
6. Arima T, Shimomura H, Nakagawa J. Treatment of non A, non B hepatitis with human fibroblast interferon. Hepatology 1986; 6: 1117. abstract.
7. Nagashima H, Arima T, Suzuki H. Treatment of chronic non-A, non-B hepatitis with human interferon-β. J Med Virol 1987; 21: 128A. abstract.
8. Thomson BJ, Doran M, Lever AML, Webster ADB. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1987; 1: 539–41.
9. Lockner D, Bratt G, Lindborg A, Tornebohm E. Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon. Acta Med Scand 1987; 221: 413–5.
10. Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report. N Engl J Med 1986; 315: 1575–8.
11. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5.
12. Yousefi S, Escobar MR, Gouldin CW. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory. Am J Clin Pathol 1985; 83: 735–40.
13. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–62.
14. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4.
15. Alter MJ, Gerety RJ, Smallwood LA, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis 1982; 145: 886–93.
16. Peters M, Davis GL, Dooley JS, Hoofnagle JH. The interferon system in acute and chronic viral hepatitis. In: Popper H, Schaffner F, eds. Progress in liver diseases. Vol. 8. New York: Grune & Stratton, 1986:453–67.
17. Davis GL, Hoofnagle JH. Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986; 6: 1038–41.
18. Soloway RD, Summerskill WH, Baggenstoss AH, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972; 63: 820–33.